May 2022
204 articles-
May 31 · 03:29Biotechnology Daily
Researchers uncover the brain's link to SIDS, setting up potential infant screening test
-
May 31 · 03:28Biotechnology Daily
Medtronic makes FTC-mandated sale to close Intersect ENT deal and scores FDA nod to boot
-
May 31 · 03:26Biotechnology Daily
FDA tags Editas' thalassemia cell therapy an orphan drug as it rounds final bend in race to clinic
-
May 31 · 03:25Biotechnology Daily
FDA clears BD's newest molecular diagnostics machine and its first test, a 3-in-one STI screener
-
May 31 · 03:23Bio Business News
BridgeBio adds another $110M to coffers with voucher sale a day after mega BMS deal
-
May 31 · 03:22Bio Business News
Roche's TIGIT flop prompts GSK, iTeos to reevaluate next steps for rival drug
-
May 31 · 03:21Bio Business News
AstraZeneca puts further $75M up for grabs in expanded Proteros cancer drug deal
-
May 31 · 03:19Bio Business News
Checkmate details bleak future if $250M Regeneron merger does not close
-
May 30 · 23:28Market Watch
European stocks extend winning streak for fourth session
-
May 30 · 23:20Market Watch
Power Corp. of Canada stock rises Monday, still underperforms market
-
May 30 · 03:22Biotechnology Daily
Paige nets European OK for AI to spot prostate cancer biomarkers
-
May 30 · 03:20Biotechnology Daily
Human Cell Atlas initiative makes strides as scientists piece together 'Google Map' of human cells
-
May 30 · 03:17Biotechnology Daily
GE Healthcare aims to bring prenatal ultrasound to the home, with investment in smartphone-scanner developer
-
May 30 · 03:15Biotechnology Daily
Caribou ready to uncork the chardonnay thanks to first-in-human CAR-T results
-
May 30 · 03:11Bio Business News
As Siemens AG leaves Russia over Ukraine war, Siemens Healthineers will stay
-
May 30 · 03:09Bio Business News
Healing the heart: Moderna co-founder, researchers near 'Holy Grail' for heart regeneration
-
May 30 · 03:07Bio Business News
Mammogram-reading AI developer Therapixel snags €15M to expand US presence
-
May 30 · 03:04Bio Business News
Bristol Myers provides Bridge over troubled water with $905M deal to enter SHP2 race
-
May 30 · 01:58Market Watch
Shell, Seven Group Sign Off on Crux Gas Field Development
-
May 27 · 04:01Biotechnology Daily
After 20 years, Boehringer vet hits the exit to become CEO at autoimmune biotech SciRhom
-
May 27 · 03:59Biotechnology Daily
FTC orders Medtronic to sell off Intersect ENT subsidiary in antitrust review
-
May 27 · 03:56Biotechnology Daily
Taiho claws back some licensing rights to lung cancer med from Cullinan in atypical, frontloaded deal
-
May 27 · 03:41Biotechnology Daily
BD, Babson set sights on bringing simple blood collection into the home
-
May 27 · 03:35Bio Business News
Former Immunomedics CFO Usama Malik indicted for insider trading, pledging to dispute 'false and speculative narrative' at trial